DMCC Speciality Chemicals Limited (NSE:DMCC)
India · Delayed Price · Currency is INR 258.45
+13.65 (5.58%)
Jun 15, 2026, 3:30 PM IST
DMCC Speciality Chemicals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 5,816 | 4,313 | 3,280 | 3,867 | 3,263 |
| 5,816 | 4,313 | 3,280 | 3,867 | 3,263 | |
Revenue Growth (YoY) | 34.84% | 31.51% | -15.18% | 18.50% | 63.03% |
Cost of Revenue | 4,425 | 2,817 | 2,114 | 2,658 | 2,106 |
Gross Profit | 1,391 | 1,496 | 1,166 | 1,209 | 1,157 |
Selling, General & Admin | 297.73 | 281.99 | 242.63 | 243.05 | 207.15 |
Other Operating Expenses | 460.09 | 639.45 | 558.35 | 577.85 | 536.22 |
Operating Expenses | 915.38 | 1,087 | 956.06 | 994.88 | 823.97 |
Operating Income | 475.4 | 409.04 | 209.81 | 213.76 | 332.65 |
Interest Expense | -96.1 | -101.82 | -132.89 | -102.1 | -38.63 |
Interest & Investment Income | - | 3.31 | 4.11 | 1.54 | 2.83 |
Currency Exchange Gain (Loss) | - | -6.09 | -4.17 | -31.35 | -6.64 |
Other Non Operating Income (Expenses) | 10.32 | 6.94 | 10.93 | 12.18 | 48.31 |
EBT Excluding Unusual Items | 389.62 | 311.39 | 87.79 | 94.02 | 338.51 |
Gain (Loss) on Sale of Investments | - | - | 84.43 | 9.87 | 0.1 |
Gain (Loss) on Sale of Assets | - | - | 0.28 | 2.09 | 2.84 |
Asset Writedown | - | - | - | -0.02 | -0.03 |
Pretax Income | 389.62 | 311.39 | 172.5 | 105.95 | 341.42 |
Income Tax Expense | 116.34 | 96.11 | 56.62 | 36.65 | 128.02 |
Net Income | 273.29 | 215.28 | 115.89 | 69.31 | 213.4 |
Net Income to Common | 273.29 | 215.28 | 115.89 | 69.31 | 213.4 |
Net Income Growth | 26.95% | 85.76% | 67.21% | -67.52% | -34.50% |
Shares Outstanding (Basic) | 25 | 25 | 25 | 25 | 25 |
Shares Outstanding (Diluted) | 25 | 25 | 25 | 25 | 25 |
Shares Change (YoY) | -0.02% | - | - | - | - |
EPS (Basic) | 10.96 | 8.63 | 4.65 | 2.78 | 8.56 |
EPS (Diluted) | 10.96 | 8.63 | 4.65 | 2.78 | 8.56 |
EPS Growth | 26.97% | 85.76% | 67.21% | -67.52% | -34.50% |
Free Cash Flow | -237.72 | 310.28 | 194.32 | 79.75 | -474.72 |
Free Cash Flow Per Share | -9.53 | 12.44 | 7.79 | 3.20 | -19.03 |
Dividend Per Share | 2.500 | 2.500 | 1.000 | - | 1.000 |
Dividend Growth | - | 150.00% | - | - | -50.00% |
Gross Margin | 23.91% | 34.68% | 35.55% | 31.26% | 35.45% |
Operating Margin | 8.17% | 9.48% | 6.40% | 5.53% | 10.20% |
Profit Margin | 4.70% | 4.99% | 3.53% | 1.79% | 6.54% |
Free Cash Flow Margin | -4.09% | 7.19% | 5.92% | 2.06% | -14.55% |
EBITDA | 632.95 | 573.48 | 363.71 | 386.45 | 412.05 |
EBITDA Margin | 10.88% | 13.30% | 11.09% | 9.99% | 12.63% |
D&A For EBITDA | 157.55 | 164.44 | 153.9 | 172.69 | 79.41 |
EBIT | 475.4 | 409.04 | 209.81 | 213.76 | 332.65 |
EBIT Margin | 8.17% | 9.48% | 6.40% | 5.53% | 10.20% |
Effective Tax Rate | 29.86% | 30.87% | 32.82% | 34.59% | 37.50% |
Revenue as Reported | 5,826 | 4,326 | 3,384 | 3,896 | 3,324 |